All-trans retinoic acid plus low doses of cytarabine for the treatment of "poor-risk" acute myeloid leukemias.

A Venditti; R Stasi; M Masi; G Del Poeta; C Cox; A Franchi; D Piccioni; A Bruno; U Coppetelli; M Tribalto

doi:10.1007/BF01695884

All-trans retinoic acid plus low doses of cytarabine for the treatment of "poor-risk" acute myeloid leukemias.

Identifier:nobleid.org/w1/20260515/CD3BC8C5

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CD3BC8C5.svg?ark=w1%2F20260515%2FCD3BC8C5)](https://nobleid.org/work/w1/20260515/CD3BC8C5)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

All-trans retinoic acid plus low doses of cytarabine for the treatment of "poor-risk" acute myeloid leukemias.

Identifier:nobleid.org/w1/20260515/CD3BC8C5

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CD3BC8C5.svg?ark=w1%2F20260515%2FCD3BC8C5)](https://nobleid.org/work/w1/20260515/CD3BC8C5)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work